Insmed (INSM) Revenue (2010 - 2026)
Insmed (INSM) posted quarterly Revenue of $306.0 million for Q1 2026, up 229.62% year-over-year from $92.8 million in Q1 2025, and up 15.96% quarter-over-quarter from $263.8 million in Q4 2025.
Insmed (INSM) Revenue (2010 - 2026) Analysis & Trends
Insmed's Revenue history runs 12 years deep, the most recent figure standing at $306.0 million for Q1 2026.
- In Q1 2026, Revenue rose 229.62% year-over-year to $306.0 million; the TTM figure through Mar 2026 stood at $819.6 million (up 115.09% YoY), while the FY2025 annual figure was $606.4 million, up 66.73% from the prior year.
- Revenue for Q1 2026 stood at $306.0 million, up from $263.8 million in the prior quarter.
- The five-year high for Revenue was $306.0 million in Q1 2026, with the low at $53.1 million in Q1 2022.
- The 5-year median for Revenue is $83.7 million (2023), against an average of $107.5 million.
- The sharpest annual moves came in 2022 and 2026: Revenue increased 5.66% in 2022, then surged 229.62% in 2026.
- Insmed's Revenue stood at $59.3 million in 2022, then surged by 41.13% to $83.7 million in 2023, then advanced by 24.79% to $104.4 million in 2024, then jumped by 152.62% to $263.8 million in 2025, then grew by 15.96% to $306.0 million in 2026.
- Business Quant data shows INSM's Revenue at $306.0 million in Q1 2026, $263.8 million in Q4 2025, and $142.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 1.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 425.49 Mn |
| Mar 31, 2026 | 305.96 Mn |
| Dec 31, 2025 | 263.84 Mn |
| Sep 30, 2025 | 142.34 Mn |
| Jun 30, 2025 | 107.42 Mn |
| Mar 31, 2025 | 92.82 Mn |
| Dec 31, 2024 | 104.44 Mn |
| Sep 30, 2024 | 93.43 Mn |
| Jun 30, 2024 | 90.34 Mn |
| Mar 31, 2024 | 75.50 Mn |
| Dec 31, 2023 | 83.69 Mn |
| Sep 30, 2023 | 79.07 Mn |
| Jun 30, 2023 | 77.23 Mn |
| Mar 31, 2023 | 65.21 Mn |
| Dec 31, 2022 | 59.30 Mn |
| Sep 30, 2022 | 67.73 Mn |
| Jun 30, 2022 | 65.22 Mn |
| Mar 31, 2022 | 53.11 Mn |
| Dec 31, 2021 | 56.12 Mn |
| Sep 30, 2021 | 46.76 Mn |